Methods of treating eye disorders with APLNR antagonists and VEGF inhibitors

• 收藏
• 分享

专利权人:

Inc.;Regeneron Pharmaceuticals

发明人:

Cao, Jingtai,Cheung, Eunice,Lobov, Ivan B.

申请号：

AU2018266324

公开号：

AU2018266324A1

申请日:

2018.05.04

申请国别(地区):

AU

年份:

2019

代理人:

摘要：

The present disclosure provides methods for treating, preventing or reducing the severity of an eye disease. The methods of the present disclosure comprise administering to a subject in need thereof a therapeutic composition comprising an APLNR antagonist such as an anti-APLNR antibody in combination with a vascular endothelial growth factor (VEGF) antagonist (for example, aflibercept).

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/